The Canadian Bioceutical Corporation is looking for acquisition opportunities. Canadian Bioceutical will pursue attractively priced acquisition opportunities throughout the U.S. Many operations in the U.S., though profitable, are small and undercapitalized and require a financially strong partner to pursue further growth. Canadian Bioceutical has completed a private placement for gross proceeds of $27 million. Canadian Bioceutical intends to use the remaining $12 million of the gross proceeds to build out a new cultivation facility in Mesa, Arizona to support further acquisitions, and for general working capital.